SCHEMBL7926748

SCHEMBL7926748

CC(C)(COCc1ccccc1)[N+]([O-])=Cc1ccc(F)cc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.36
ACHE P22303 2/20 0.36
BACE1 P56817 2/20 0.36
NFE2L2 Q16236 1/20 0.35
GRM5 P41594 1/20 0.35
BCHE P06276 1/20 0.35
DHODH Q02127 1/20 0.35
TACR1 P25103 1/20 0.34
CHRM3 P20309 3/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
KCNH2 Q12809 1/20 0.33
KDM4E B2RXH2 1/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 2/20 0.33
PPIA P62937 1/20 0.32
MAOB P27338 1/20 0.32
NR3C1 P04150 1/20 0.32
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7914568 0.81 NFE2L2 (0.32) NFE2L2POLBMAPT
SCHEMBL8441698 0.81 NFE2L2 (0.35) NFE2L2HTR2AHTR2CKCNH2POLB
SCHEMBL7921545 0.76 ACHE (0.36) ARACHEBACE1NFE2L2GRM5
SCHEMBL7926808 0.76 POLB (0.40) HTR2AHTR2CKCNH2KDM4EPOLB
SCHEMBL7914607 0.75 PTGS1 (0.37) NFE2L2HTR2AHTR2CKCNH2POLB
SCHEMBL7923573 0.73 NFE2L2 (0.42) NFE2L2HTR2AHTR2CKCNH2
SCHEMBL7921427 0.69 TSHR (0.47) TACR1KDM4EPOLBTSHRMAOB
SCHEMBL7923592 0.67 PTGS1 (0.37) NFE2L2HTR2AHTR2CKCNH2KDM4E
SCHEMBL11414043 0.67 ALDH1A1 (0.61) ACHEBACE1NFE2L2HTR2AHTR2C
SCHEMBL7922819 0.67 PTGS1 (0.31) NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194461-B1 USEFUL AS MEDICAMENT FOR TREATING RETINAL DEGENERATIVE DISORDERS; ALPHA-(2,4-DIFLUOROPHENYL)-N-T-BUTYLNITRONE, AND CORRESPONDING AMINES WHICH WOULD BE CONVERTED IN VIVO TO THE NITRONE, FOR EXAMPLE SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-02-27 US disclosed
EP-0945426-A1 NITRONE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1999-09-29 EP disclosed